US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRAIL, Inc.

33.23

+0.44001.34%

Volume:613.36K

Turnover:20.27M

Market Cap:1.20B

PE:-0.57

High:33.40

Open:33.24

Low:32.50

Close:32.79

Loading ...

Overview Company News Filings

Grail Inc. GRAIL to Announce Second Quarter 2025 Financial Results

Aaron Freidin, CFO, Reports Disposal of Common Shares of Grail Inc

Chun R. Ding, 10% Owner, Reports Disposal of Common Shares of Grail Inc

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live

Grail Says Galleri Showed Greater Cancer Detection in Pathfinder 2 Study Versus Prior Study; Shares Up

MT Newswires Live

BRIEF-GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study

GRAIL Inc. Advances Galleri® MCED Test with FDA Premarket Approval Application, Expects Completion by 2026

BUZZ-U.S. STOCKS ON THE MOVE-Copper miners, Chip Stocks, EchoStar

BUZZ-Cancer test maker Grail falls after Ningi Research's short position

NINGI short Grail, says ‘approval and commercialization all but impossible’

BRIEF-Ningi Research Says Short Grail

Grail Inc. Conducted Annual Stockholders Meeting

Grail Inc. Announces New Equity Inducement Plan for Recently Hired Employees

New Tests Promise to Reveal the Secrets in Your Blood -- Journal Report

Grail Inc. Announces New Compensation Agreement for Top Executives with Enhanced Severance Benefits

Stock Track | GRAIL Shares Plummet 5.03% as Investors Digest Q1 Revenue Miss

Stock Track | GRAIL Plunges 14.90% After-Hours on Q1 Revenue Miss Despite Narrower Loss

BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment

GRAIL Is Maintained at Buy by Canaccord Genuity

Stock Track | GRAIL Plummets 16.58% Pre-market on Q1 Revenue Miss, Overshadowing Positive Developments

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GRAL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":33.23,"timestamp":1754337600000,"preClose":32.79,"halted":0,"volume":613361,"delay":0,"floatShares":24099359,"shares":35973494,"eps":-58.51757,"marketStatus":"Pre-Mkt","change":0.44,"latestTime":"08-05 07:50:03 EDT","open":33.24,"high":33.4,"low":32.5,"amount":20271615.398215998,"amplitude":0.027447,"askPrice":33.99,"askSize":38,"bidPrice":32.67,"bidSize":38,"shortable":3,"etf":0,"ttmEps":-58.51757,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1754400600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":33.23,"postHourTrading":{"tag":"盘后","latestPrice":33,"preClose":33.23,"latestTime":"19:55 EDT","volume":6781,"amount":225260.458,"timestamp":1754351748353},"volumeRatio":0.6237315348369166,"impliedVol":0.997,"impliedVolPercentile":0.5622},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":24099359,"roa":"-11.99%","roe":"-62.22%","lyrEps":-63.539968,"volumeRatio":0.6237315348369166,"shares":35973494,"dividePrice":0,"high":33.4,"amplitude":0.027447,"preClose":32.79,"low":32.5,"week52Low":12.33,"pbRate":"0.50","psRate":"9.15","week52High":63.99,"institutionHeld":0,"latestPrice":33.23,"eps":-58.51757,"divideRate":0,"volume":613361,"delay":0,"ttmEps":-58.51757,"open":33.24,"prevYearClose":17.85,"prevWeekClose":32.79,"prevMonthClose":34.21,"prevQuarterClose":51.42,"fiveDayClose":38.27,"twentyDayClose":44.85,"sixtyDayClose":34.71,"earningDate":1754928000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555264066","title":"Grail Inc. GRAIL to Announce Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2555264066","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555264066?lang=en_us&edition=fundamental","pubTime":"2025-07-30 04:02","pubTimestamp":1753819336,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via PR Newswire  on July 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nNDL8kW2C7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2552434744","title":"Aaron Freidin, CFO, Reports Disposal of Common Shares of Grail Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2552434744","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552434744?lang=en_us&edition=fundamental","pubTime":"2025-07-18 05:44","pubTimestamp":1752788698,"startTime":"0","endTime":"0","summary":"Aaron Freidin, Chief Financial Officer of Grail Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL9JWRQ3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2548387198","title":"Chun R. Ding, 10% Owner, Reports Disposal of Common Shares of Grail Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2548387198","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548387198?lang=en_us&edition=fundamental","pubTime":"2025-07-04 04:32","pubTimestamp":1751574734,"startTime":"0","endTime":"0","summary":"Chun R. Ding, a 10% Owner, reported a disposal of common shares of Grail Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nNDL5SYxvw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2544542900","title":"Sector Update: Health Care Stocks Softer Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2544542900","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544542900?lang=en_us&edition=fundamental","pubTime":"2025-06-19 03:49","pubTimestamp":1750276154,"startTime":"0","endTime":"0","summary":"Health care stocks were decreasing late Wednesday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund  easing 0.1%.The iShares Biotechnology ETF  rose 0.4%.In sector news, US Secretary of Health and Human Services Robert Kennedy Jr. is weighing a proposal for a key government vaccine advisory panel to scrutinize vaccines with aluminum ingredients, Bloomberg reported. A review could impact at least two dozen vaccines, the report said.In corporate news, Zoetis  shares were falling 3.7% after Stifel downgraded the stock to hold from buy and cut its price target to $160 from $165.Gilead Sciences  shares added 0.3% after the drugmaker said the US Food and Drug Administration has approved its Yeztugo, its twice-yearly injectable for HIV prevention.Caris Life Sciences  shares surged 23% in their Nasdaq debut Wednesday after the company priced its IPO of 23.5 million shares at $21 each.Grail  shares jumped 13% after the firm said it has seen better ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0234570918.USD","LU1571399168.USD","LU2089984988.USD","LU0320765992.SGD","LU0823416689.USD","LU1941712348.USD","XLV","GRAL","BK4139","BK4568","LU2271345857.HKD","IE00B3T34201.USD","LU2089283258.USD","BK4588","GILD","MAIA","IE00BSNM7G36.USD","IE00B19Z9505.USD","LU0471298777.SGD","IE00B19Z3B42.SGD","LU2028103732.USD","LU0471298694.HKD","LU1839511570.USD","ZTS","LU2023251221.USD","BK4581","LU2308191902.HKD","LU1066051498.USD","LU1585245621.USD","IE0002270589.USD","LU0889565916.HKD","LU1066053197.SGD","BK4550","CAI.AU","BK4585","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU1674673428.USD","BK7104","BK4007","BK4532","LU2360106947.USD","LU0058720904.USD","BK4104","LU0385154629.USD","LU0345774631.USD","LU0158827948.USD","IBB","CAI","LU2087621335.USD"],"gpt_icon":0},{"id":"2544293908","title":"Grail Says Galleri Showed Greater Cancer Detection in Pathfinder 2 Study Versus Prior Study; Shares Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2544293908","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544293908?lang=en_us&edition=fundamental","pubTime":"2025-06-18 21:48","pubTimestamp":1750254521,"startTime":"0","endTime":"0","summary":"Grail  said Wednesday it has seen better cancer detection results from an analysis of the first 25,578 participants in its Pathfinder 2 study compared with the previous Pathfinder study.The Pathfinder 2 study was launched in 2021 to assess the safety and performance of the Galleri cancer detection test when added to standard of care in 35,878 adults with more than 50 years of age and with no clinical suspicion of cancer, Grail said.In Pathfinder 2, adding Galleri to standard of care tests showed \"substantially greater additional cancer detection\" than in the prior study, the company said.The results from the latest study also indicated a \"substantially higher\" positive predictive value than that seen in the previous study, Grail said.The company also said \"no serious safety concerns\" were seen in the Pathfinder 2 study.Grail shares were up more than 4% in recent early trading.Price: 43.97, Change: +1.92, Percent Change: +4.57","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","PBHC","GRAL","BK4139"],"gpt_icon":0},{"id":"2544707129","title":"BRIEF-GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2544707129","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544707129?lang=en_us&edition=fundamental","pubTime":"2025-06-18 21:24","pubTimestamp":1750253074,"startTime":"0","endTime":"0","summary":"BRIEF-GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational StudyJune 18 (Reuters) - Grail Inc GRAL.O:GRAIL ANNOUNCES POSITIVE TOP-LINE RESULTS FROM THE GALLERI PATHFI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nTUA96JFPJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2544970381","title":"GRAIL Inc. Advances Galleri® MCED Test with FDA Premarket Approval Application, Expects Completion by 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2544970381","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544970381?lang=en_us&edition=fundamental","pubTime":"2025-06-18 21:02","pubTimestamp":1750251726,"startTime":"0","endTime":"0","summary":"GRAIL, Inc., a healthcare company focused on early cancer detection, announced progress in the regulatory review process for its Galleri multi-cancer early detection  test. The company is in the midst of a Premarket Approval  submission to the U.S. Food and Drug Administration  under a Breakthrough Device Designation. The submission is modular, with GRAIL anticipating completion in the first half of 2026. The PATHFINDER 2 study results, demonstrating enhanced cancer detection and safety, will be part of this application. Additionally, bridging analyses comparing different versions of Galleri will be included. There were no safety concerns reported in the study, further supporting the test's reliability.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL2xcWZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2542331759","title":"BUZZ-U.S. STOCKS ON THE MOVE-Copper miners, Chip Stocks, EchoStar","url":"https://stock-news.laohu8.com/highlight/detail?id=2542331759","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542331759?lang=en_us&edition=fundamental","pubTime":"2025-06-10 01:46","pubTimestamp":1749491181,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Copper miners, Chip Stocks, EchoStarEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nL6N3SC0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NOVAQ","EIX","3NVD.UK","OMH","RSLS","FCX","MCD","MRK","CODI","UNFI","ENTG","COOK","ENPH","FE","AXSM","EAF","CCJ","AWE.UK","PCG","NUWE","NVD2.UK","MTSR","ON","2NVD.UK","UHS","BHP.AU","QCOM","ODD","PLCE","RFL","ISRG","WLGS","BKNG","VHC","GRAL","NOVA","SATS","SCCO","ALB","CTXR"],"gpt_icon":1},{"id":"2542480335","title":"BUZZ-Cancer test maker Grail falls after Ningi Research's short position","url":"https://stock-news.laohu8.com/highlight/detail?id=2542480335","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542480335?lang=en_us&edition=fundamental","pubTime":"2025-06-09 23:17","pubTimestamp":1749482245,"startTime":"0","endTime":"0","summary":"BUZZ-Cancer test maker Grail falls after Ningi Research's short position** Shares of cancer diagnostic maker Grail GRAL.O falls 3% to $37.16 ** Ningi Research says it is short on Grail's position citing co's \"overly ambitious approach\" to cancer screening that has created \"insurmountable regulatory roadblocks\"** \"We believe Grail's cancer detection test is backed by data that is just enough to create investor hype, but far too weak to convince experts, regulators, or insurers of its clinical utility,\" says Ningi in its report** Ningi says co's actual sales have \"massively underperformed projections\"** GRAL stock up more than double YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nL4N3SC13F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":1},{"id":"2542333451","title":"NINGI short Grail, says ‘approval and commercialization all but impossible’","url":"https://stock-news.laohu8.com/highlight/detail?id=2542333451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542333451?lang=en_us&edition=fundamental","pubTime":"2025-06-09 22:35","pubTimestamp":1749479720,"startTime":"0","endTime":"0","summary":"In a recently published report, NINGI Research says it is short Grail (GRAL), arguing that “the company’s overly ambitious approach to cancer scree...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ningi-short-grail-says-approval-and-commercialization-all-but-impossible-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ningi-short-grail-says-approval-and-commercialization-all-but-impossible-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2542333300","title":"BRIEF-Ningi Research Says Short Grail","url":"https://stock-news.laohu8.com/highlight/detail?id=2542333300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542333300?lang=en_us&edition=fundamental","pubTime":"2025-06-09 22:23","pubTimestamp":1749479033,"startTime":"0","endTime":"0","summary":"BRIEF-Ningi Research Says Short GrailJune 9 (Reuters) - NINGI RESEARCH SAYS SHORT GRAILSource text: https://tinyurl.com/5bmzhr4vFurther company coverage: GRAL.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA0AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2539203881","title":"Grail Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2539203881","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539203881?lang=en_us&edition=fundamental","pubTime":"2025-05-31 05:05","pubTimestamp":1748639157,"startTime":"0","endTime":"0","summary":"Grail Inc. held its Annual Meeting of Stockholders on May 29, 2025. At the meeting, stockholders elected William Chase as a Class I Director. Additionally, stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Both proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL8Pf9K7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2539270182","title":"Grail Inc. Announces New Equity Inducement Plan for Recently Hired Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2539270182","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539270182?lang=en_us&edition=fundamental","pubTime":"2025-05-31 04:05","pubTimestamp":1748635522,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. , a healthcare company focused on early cancer detection, has announced the issuance of equity awards to 38 newly hired non-executive employees. These awards, in the form of restricted stock units  totaling 77,350 shares of GRAIL's common stock, serve as inducements for their acceptance of employment. The awards were granted under GRAIL's Inducement Equity Incentive Plan in alignment with Nasdaq Listing Rule 5635. The RSUs will vest over approximately four years, with 25% vesting on May 31, 2026, and subsequent vesting on each anniversary of this date, contingent on continued employment with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL60kcMB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2537327851","title":"New Tests Promise to Reveal the Secrets in Your Blood -- Journal Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2537327851","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537327851?lang=en_us&edition=fundamental","pubTime":"2025-05-23 22:00","pubTimestamp":1748008800,"startTime":"0","endTime":"0","summary":"Blood tests have long been an important tool for giving doctors a picture of a patient's health, from cholesterol levels to diabetes risk. Now new genetic science, AI analysis and other advances are providing even more sophisticated information from a simple vial of blood.A wave of cutting-edge diagnostic tests can now identify diseases such as cancer and Alzheimer's at much earlier stages, sometimes long before symptoms appear, as well as manage chronic disease and tailor treatments to individual patients. And new data derived from blood can help tailor treatments to individual patients.A number of the most sophisticated tests have already received approval or clearance from the Food and Drug Administration or are seeking it. Some new tests have been developed by labs that are certified to meet federal quality standards, so they can market the tests without FDA authorization. The agency is currently reviewing its policies to ensure such tests meet higher regulatory standards for accur","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0251142724.SGD","BK4535","BK4139","LU0048573561.USD","BK4550","LU0006061336.USD","LU0742534661.SGD","GH","LH","BK4551","BK4585","LU1059921491.USD","BK4588","LU0251131958.USD","BK4196","GRAL"],"gpt_icon":0},{"id":"2536406623","title":"Grail Inc. Announces New Compensation Agreement for Top Executives with Enhanced Severance Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2536406623","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536406623?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:06","pubTimestamp":1747425996,"startTime":"0","endTime":"0","summary":"Grail Inc. has announced new compensation terms for its top executives, as approved by the Compensation Committee of the Board of Directors. The amended offer letters for President Josh Ofman and Chief Financial Officer Aaron Freidin confirm their annual base salaries at $655,000 and $560,000, respectively, with the possibility of future increases. Both executives will continue to be eligible for a target bonus of 50% of their base salaries under the company's Variable Compensation Plan. The new terms also outline severance benefits, including a lump sum cash payment equal to 12 months of their annual base salary and target bonus, 12 months of healthcare coverage, and acceleration of any equity awards held. These provisions will apply if either executive is terminated without cause or resigns for good reason, subject to certain conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL5jnqPb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"1108527984","title":"Stock Track | GRAIL Shares Plummet 5.03% as Investors Digest Q1 Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=1108527984","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108527984?lang=en_us&edition=fundamental","pubTime":"2025-05-16 23:54","pubTimestamp":1747410861,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. , a healthcare company specializing in early cancer detection, saw its stock plummet 5.03% during Friday's intraday trading session. This decline appears to be a continued reaction to the company's disappointing first-quarter 2025 financial results released earlier in the week.The sustained sell-off follows GRAIL's after-hours plunge of 14.90% on Tuesday when the company reported its Q1 earnings. Despite posting a narrower-than-expected loss of $3.10 per share, beating analyst estima","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"1117497277","title":"Stock Track | GRAIL Plunges 14.90% After-Hours on Q1 Revenue Miss Despite Narrower Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1117497277","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117497277?lang=en_us&edition=fundamental","pubTime":"2025-05-16 14:43","pubTimestamp":1747377823,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. , a healthcare company focused on early cancer detection, saw its stock plummet 14.90% in after-hours trading on Tuesday following the release of its first-quarter 2025 financial results. The sharp decline came despite the company reporting a narrower-than-expected loss, as revenue fell short of analyst expectations.For the quarter ended March 31, GRAIL reported revenue of $31.8 million, up from $26.7 million a year earlier but significantly below the $35.2 million forecast by analys","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"2535045005","title":"BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535045005","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535045005?lang=en_us&edition=fundamental","pubTime":"2025-05-15 01:55","pubTimestamp":1747245319,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera InvestmentEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL6N3RM0OJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["2NVD.UK","MESA","NVDD","SRE","ANTA","BLUE","LEGN","HTZ","MRP","NVD","EXEL","NVDU","NVIW.SI","NXT","MAGN","PVH","MP","RTX","TXO","CG","3NVD.UK","GRAL","CIM","AUR","KKR","FRGE","EWCZ","NFE","SEPN","ABBV","NEXT","AEO","GPI","OKLO","SNVD.UK","NVDS.UK","SPRU","NVD2.UK","LOAR","JCI","HOOD","NEM"],"gpt_icon":1},{"id":"2535607218","title":"GRAIL Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2535607218","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535607218?lang=en_us&edition=fundamental","pubTime":"2025-05-14 23:55","pubTimestamp":1747238100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRAL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2025 11:55 ET (15:55 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"gpt_icon":0},{"id":"1155418022","title":"Stock Track | GRAIL Plummets 16.58% Pre-market on Q1 Revenue Miss, Overshadowing Positive Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=1155418022","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155418022?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:50","pubTimestamp":1747230637,"startTime":"0","endTime":"0","summary":"GRAIL, Inc.  saw its stock plummet 16.58% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results. The sharp decline came as the biotechnology company's revenue fell significantly short of analyst expectations, overshadowing other positive developments.Despite the revenue shortfall, GRAIL announced encouraging results from its NHS-Galleri trial, reporting positive top-line results from the prevalent screening round. The company also highlighted its st","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":79,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"date":"2025-08-12","symbol":"GRAL","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":-3.14,"defaultRemindTime":1755028800000,"name":null,"time":"Post Market","dateTimestamp":1754971200000,"actualEps":null},{"market":"US","date":"2025-05-13","symbol":"GRAL","fiscalQuarterEnding":"2025/03","expectedEps":-4.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-3.1},{"market":"US","date":"2025-02-20","symbol":"GRAL","fiscalQuarterEnding":"2024/12","expectedEps":-4.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2024-11-12","symbol":"GRAL","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-3.94},{"market":"US","date":"2024-08-13","symbol":"GRAL","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-5.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.25,"hold":0.75,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.75,"analysts":4,"updateTime":1745467200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2025-08-04","current":-0.616188,"percent":0.291188,"low":-0.966282,"twenty":-0.704548,"median":-0.373436,"eighty":-0.162007,"high":-0.135365,"avg":-0.431443,"sd":0.23941,"marketCap":1179570868},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-25","current":-0.630246,"twenty":-0.466372,"median":-0.283965,"eighty":-0.151863,"marketCap":1277511821},{"date":"2025-05-02","current":-0.565758,"twenty":-0.478944,"median":-0.287218,"eighty":-0.15253,"marketCap":1146794916},{"date":"2025-05-09","current":-0.62862,"twenty":-0.498389,"median":-0.292296,"eighty":-0.15337,"marketCap":1274216573},{"date":"2025-05-16","current":-0.732698,"twenty":-0.51302,"median":-0.295346,"eighty":-0.153995,"marketCap":1402606531},{"date":"2025-05-23","current":-0.728564,"twenty":-0.527433,"median":-0.296725,"eighty":-0.154728,"marketCap":1394692362},{"date":"2025-05-30","current":-0.772349,"twenty":-0.542338,"median":-0.298484,"eighty":-0.155417,"marketCap":1478510603},{"date":"2025-06-06","current":-0.742094,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"marketCap":1420593278},{"date":"2025-06-13","current":-0.787758,"twenty":-0.602918,"median":-0.308322,"eighty":-0.156041,"marketCap":1508008868},{"date":"2025-06-20","current":-0.910282,"twenty":-0.617043,"median":-0.310838,"eighty":-0.156127,"marketCap":1742556049},{"date":"2025-06-27","current":-0.927946,"twenty":-0.628237,"median":-0.313683,"eighty":-0.156967,"marketCap":1776371133},{"date":"2025-07-03","current":-0.87796,"twenty":-0.640897,"median":-0.324667,"eighty":-0.158949,"marketCap":1680681639},{"date":"2025-07-11","current":-0.815382,"twenty":-0.656882,"median":-0.33641,"eighty":-0.159595,"marketCap":1560889904},{"date":"2025-07-18","current":-0.675007,"twenty":-0.694504,"median":-0.351643,"eighty":-0.160456,"marketCap":1292167904},{"date":"2025-07-25","current":-0.746416,"twenty":-0.703946,"median":-0.35847,"eighty":-0.160672,"marketCap":1428867181},{"date":"2025-08-01","current":-0.642872,"twenty":-0.704698,"median":-0.372061,"eighty":-0.161318,"marketCap":1230653229},{"date":"2025-08-04","current":-0.616188,"twenty":-0.704548,"median":-0.373436,"eighty":-0.162007,"marketCap":1179570868}],"updateTime":1754394603093}}}